Rapid effects of a single high dose of simvastatin on C-reactive protein in patients with unstable angina

HeartDrug

Volumn 5, Issue 3, 2005, Pages 140-145

  Li, Jian Jun ^a,b   Fang, Chun Hong ^a   Chen, Ming Zhe ^b   Chen, Xin ^b  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b Tsinghua University   (China)

Author keywords

Angina; C reactive protein; Lipid profile; Prognosis; Simvastatin; Stenosis; Unstable angina

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; NITRATE; SIMVASTATIN;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HIGH RISK POPULATION; HOSPITAL ADMISSION; HUMAN; INFLAMMATION; MALE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; THORAX PAIN; UNSTABLE ANGINA PECTORIS; VASCULAR ENDOTHELIUM;

EID: 20944449839     PISSN: 14229528     EISSN: None     Source Type: Journal    
DOI: 10.1159/000085887     Document Type: Article

References (23)

1. Maseri A: Inflammation, atherosclerosis, and ischemic events: Exploring the hidden side of the moon. N Engl J Med 1997;336:1014-1016.
2. Ross R: Atherosclerosis - An inflammatory disease. N Engl J Med 1999;340:115-126.
3. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH: Inflammation, aspirin and risks of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973-979.
4. Libby P, Ridker PM: Novel inflammatory markers of coronary risk: Theory versus practice. Circulation 1999;100:1148-1150.
5. Ridker PM: High-sensitivity C-reactive protein: Potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 2001;103:1813-1818.
6. Ferranti SD, Rifai N: C-reactive protein and cardiovascular disease: A review of risk prediction and interventions. Clin Chim Acta 2002;317:1-15.
7. Clyne B, Olshaker JS: The C-reactive protein. J Emerg Med 1999;17:1019-1025.
8. Kolb-Bachofen V: A review on the biological properties of C-reactive protein. Immunobiology 1991;183:133-145.
9. Ballou SP, Kushner I: C-reactive protein and the acute phase response. Adv Intern Med 1992;37:313-336.
10. Li J-J, Jiang H, Huang C-X, Fang C-H, Tang Q-Z, Xia H, Liu J, Li G-S: Elevated levels of plasma C-reactive protein in patients with unstable angina: Its relations with coronary stenosis and lipid profile. Angiology 2002;53:265-272.
11. Jackson G: The role of statins in acute coronary syndromes: Managing the unmet need. Int J Clin Pract 2000;54:445-449.
12. Szucs TD: Pharmaco-economic aspects of lipid-lowering therapy: Is it worth the price? Eur Heart J 1998;19(suppl M):M22-M28.
13. Fairhurst K, Huby G: From trial data to practical knowledge: Qualitative study of how general practitioners have accessed and used evidence about statin drugs in their management of hypercholesterolaemia. BMJ 1998;317:1130-1134.
14. Azar RR, Waters DD, Lebanon B: PRINCE'S prospects: Statin, inflammation, and coronary risk. Am Heart J 2001;141:881-883.
15. Li J-J, Chen M-Z, Chen X, et al: Rapid effects of simvastatin on lipid profile and C-reactive protein in patients with hypercholesterolemia. Clin Cardiol 2003;26:472-476.
16. Li J-J, Chen X-J: Simvastatin inhibits interleukin-6 release in human monocytes stimulated by C-reactive protein and lipopolysaccharide. Coron Artery Dis 2003;14:329-334.
17. Treasure CB, Klein JL, Weintraub WS, et al: Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med 1995;332:481-487.
18. Schrott HG, Knapp H, Davila M, et al: Effect of atorvastatin on blood lipid levels in the first 2 weeks of treatment: A randomized, placebo-controlled study. Am Heart J 2000;140:249-252.
19. Ridker PM, Rifai N, Lowenthal SP: Rapid reduction in C-reactive protein with cerivastatin among 785 patients with primary hypercholesterolemia. Circulation 2001;103:1191-1193.
20. Plenge JK, Hernandez TL, Weil KM, et al: Simvastatin lowers C-reactive protein within 14 days: An effect independent of low-density lipoprotein cholesterol reduction. Circulation 2002;106:1447-1452.
21. Heeschen C, Hamm CW, Laufs U, et al: Withdrawal of statins increases event rates in patients with acute coronary syndromes. Circulation 2002;105:1446-1452.
22. Ridker PM, Rifai N, Pfeffer MA, et al: Long-term effects of pravastatin on plasma concentration of C-reactive protein. Circulation 1999;100:230-235.
23. Ostadal P, Alan D, Hajek P, et al: The effect of early treatment by cerivastatin on the serum level of C-reactive protein, interleukin-6, and interleukin-8 in the patients with unstable angina and non-Q-wave myocardial infarction. Mol Cell Biochem 2003;246:45-50.